Synthego

Redwood City, United States Founded: 2012 • Age: 14 yrs Acquired By Perceptive Advisors
CRISPR-engineered cell and gene therapies are developed for research applications.
Request Access

About Synthego

Synthego is a company based in Redwood City (United States) founded in 2012 was acquired by Perceptive Advisors in June 2025.. Synthego has raised $459.75 million across 8 funding rounds from investors including ARE, RA Capital and SoftBank Vision Fund. Synthego operates in a competitive market with competitors including Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others.

  • Headquarter Redwood City, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Synthego Corporation
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $459.75 M (USD)

    in 8 rounds

  • Latest Funding Round
    $200 M (USD), Series E

    Feb 17, 2022

  • Investors
    ARE

    & 23 more

  • Employee Count
    Employee Count
  • Acquired by
    Perceptive Advisors

    (Jun 26, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Synthego
Headcount 200-500
Employee Profiles 29
Employee Profiles
People
Jason Miller
Chief Commercial Officer
People
Shannon Leary
Chief Of Staff
People
Ngoc L.
Senior Director Of Operations, CR & GMP
People
Ruby Fernandez-de Casas
GMP Proposal Writer

Unlock access to complete

Funding Insights of Synthego

Synthego has successfully raised a total of $459.75M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $200 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series E — $200.0M
  • First Round

    (12 Jun 2012)

  • Investors Count 24
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2022 Amount Series E - Synthego Valuation Perceptive Advisors
Aug, 2020 Amount Series D - Synthego Valuation RA Capital Management , 8VC
Oct, 2018 Amount Series C - Synthego Valuation Founders Fund
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Synthego

Synthego has secured backing from 24 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include ARE, RA Capital and SoftBank Vision Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Health-tech companies are targeted for venture capital investments.
Founded Year Domain Location
Venture capital investments in technology and startups.
Founded Year Domain Location
Venture capital firm investing in multiple sectors
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Synthego

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Synthego

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Synthego Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Synthego

Synthego operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of renewable products for industrial solutions
domain founded_year HQ Location
Crop protection solutions and hybrid seeds are provided for farming.
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Gene and protein therapies are developed for treating various diseases.
domain founded_year HQ Location
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Synthego

When was Synthego founded?

Synthego was founded in 2012.

Where is Synthego located?

Synthego is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

Is Synthego a funded company?

Synthego is a funded company, having raised a total of $459.75M across 8 funding rounds to date. The company's 1st funding round was a Series C of $110M, raised on Jun 12, 2012.

What does Synthego do?

Synthego was founded in 2012 in Redwood City, United States, and operates in the biotechnology sector focused on CRISPR genome editing. Synthetic guide RNAs, CRISPRCas9 kits in single or dual formats with optional modifications, full-length synthetic RNAs, and screening libraries are produced using automated pipelines. Collaborations with universities support CRISPR research in stem cells, primary human cells, and mouse embryos.

Who are the top competitors of Synthego?

Synthego's top competitors include Syngenta, Sutro Biopharma and Avidity Biosciences.

Who are Synthego's investors?

Synthego has 24 investors. Key investors include ARE, RA Capital, SoftBank Vision Fund, Perceptive Advisors, and WI Harper Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available